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Replacement of thymidine in DNA by halopyrimidines, such as bromodeoxyuridine 
(BrdU) and iododeoxyuridine (IdU), has long been known to enhance DNA damage and 
cell death induced by ionizing/UV radiation, but the mechanism of action of 
halopyrimidines at the molecular level is poorly understood. We have applied advanced 
time-resolved femtosecond laser spectroscopy to this molecular system of biological, 
chemical and medical significance. We obtained the first real-time observations of the 
transition states of the ultrafast electron transfer (UET) reactions of halopyrimidines with 
the ultrashort-lived precursor to the hydrated electron, which is a general product in 
ionizing/UV radiation. Our results provide a mechanistic understanding of these photo-
/radiosensitizing drugs at the molecular level.  
 
We found that the UET reaction of BrdU is completed within 0.2 picosecond (ps) after 
the electronic exciataion, leading to the formation of the transition state BrdU*− with a 
lifetime of ~1.5 ps that then dissociates into Br− and a high reactive radical dU•. We have 
also demonstrated that the reaction efficiency for the formation of the reactive radical dU• 
to cause DNA damage and cell death is in the order of IdU>>BrdU>CldU>>FdU. This is 
due to the availability of two precursor states of ~0.2 ps and ~ 0.54 ps lifetimes for 
dissociative electron attachment (DEA) to IdU, of one precursor state of ~0.2 ps lifetime 
for DEAs to BrdU and CldU, and no precursors for DEA to FdU. This explains why 
BrdU and IdU were found to be effective radio-/photosensitizers and indicates that IdU 
should be explored as the most effective radiosensitizer among halopyrimidines.  
Moreover, as a by-product of this project, these halopyrimidines have been employed as 
quantum-state-specific molecular probes to resolve a long-standing controversy about the 
nature and lifetimes of prehydrated electrons. These findings also have a broader 
significance as they indicated that nonequilibrium precursor electrons may play an 
important role in electron-initiated reactions in many biological, chemical and 
environmental systems.  
 
We have also demonstrated UET reactions of nucleotides with the precursor to the 
hydrated electrons. Our results indicate that among DNA bases, adenine is the most 
efficient electron trapper and an effective electron transfer promoter, while guanine is the 
most effective in dissociative electron attachment. These results not only primarily 
explain the sequence selectivity of duplex DNA containing BrdU/IdU, but imply that the 
DEA of guanine is an important mechanism for radiation-induced DNA damage in 
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More than one century ago, the Swedish Chemist Svante Arrhenius first concluded that 
there must exist an intermediate in the transformation from reactants to products. Later, 
this intermediate came to be known as the transition state. We need to know the 
properties of the transition state if we are to predict, understand and modify the course of 
a reaction.  Real-time observations of molecular reactions are of great importance in 
diverse fields from chemistry and biology to medicine. Time-resolved ultrafast laser 
spectroscopy is the most versatile and powerful technology for real-time observation of 
molecular reactions. It uses laser flashes of such ultrashort duration down to the time 
scale on which the reactions actually happen - femtoseconds (fs) (1fs= 10-15 seconds) [1]. 
The application of this spectroscopy to chemistry has led to the birth of a field in 
chemistry, the so-called femtochemistry [1]. Most recently, this spectroscopy has been 
extended to investigate structural and reaction dynamics of biological systems, including 
DNA, RNA and proteins [2-6]. New exciting multidisciplinary frontiers, ultrafast 
biophotonics, femtobiology and femtomedicine, which involve a fusion of ultrafast laser 
spectroscopy with biology/medicine, are being developed. 
 
  Halopyrimidines, particularly 5-Bromo-2’-deoxyuridine (BrdU) and 
5-Iodo-2’-deoxyuridine (IdU), are the most important hypoxic radiosensitizing drugs in 
radiotherapy of cancer. As potential radiosensitizers, they have passed phase I-II clinical 
trials, but they failed in phase III clinical trials. This is probably due to the poorly 
understanding of the molecular reaction mechanism of these drugs. This thesis work 
presents a new mechanistic understanding at the molecular level of halopyrimidines as 
radiosensitizing drugs, using the advanced time-resolved femtosecond laser spectroscopy. 
The transition states of the ultrafast electron transfer reactions of halopyrimidines with 
nonequilibrium prehydrated electrons are directly observed and a novel molecular 
reaction mechanism is presented in this thesis. 
 
 
1.1 Current status of cancer research 
 
Cancer diseases represent a serious public health problem since they affect many people, 
involve severe symptoms, and are a frequent cause of death. Many people experience 
these diseases as being more frightening than other conditions that may have a worse 
prognosis. Cancer results from abnormal growth of otherwise healthy cells. Cancer cells 
continue to grow and divide without restraint, eventually spreading throughout the body, 
interfering with the function of normal tissues and organs, and progressively leading to 
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death [7-9]. Cancer as a disease in the human population is becoming a larger health 
problem due to the increasing in aging and the medicines used as treatments have clear 
limitations [10]. 
   
Typically when a cancer is physically detected, it has been developing for a certain 
period of time. As time equates with increased cellular changes towards aggressiveness, it 
follows that the earlier a cancer can be detected, the fewer changes it has resulted in and 
the more likelihood there will be of getting a good response to treatment. Early detection 
of very small or pre-malignant growths should result in more cures.  It is possible to 
screen vulnerable populations for the pre-malignant signs or early stages of some cancers. 
Screening large numbers of people for early signs of cancer should therefore be beneficial, 
provided that a suitable test is available. In order to be effective, such screening must be 
applied to all the population at risk; it is useful only in cancers where there is a 
reasonable chance of a cure. Screening is expensive, and so it is used only for a few 
cancers and only in countries that can afford it. When pre-malignant or early malignant 
stages are detected by screening, prompt treatment can halt the progress of the disease. It 
is more usual that the patient detects symptoms and reports these to a doctor, who then 
makes a preliminary diagnosis and refers the patient to a hospital with specialised staff 
and better diagnostic tools. Hospital examination may include imaging, biopsy to provide 
material for histopathology and clinical biochemistry. If the diagnosis is confirmed, then 
the state of development of the cancer (staging) is established, because the type of 
treatment is determined by the stage [7-9].  
 
As cancer therapy is radical and involves several types of treatment, it is delivered by 
teams of specialists working in large hospitals. The principal therapeutic modalities are 
surgery, radiotherapy, chemotherapy and the emerging photodynamic therapy (PDT), 
although other disciplines such as imaging, nursing and psychology provide important 
components in the whole treatment. 
  
Surgery, commonly combining with radiotherapy, is the primary treatment method for 
most cancers, and also for later removal of tumour residuals or recurring tumours. The 
primary aim of surgery is to remove the entire tumour and, when appropriate, any 
metastases in regional lymphatics. This is the cornerstone of treatment for solid tumours, 
and it can, in some cases, result in a complete cure. In earlier times, cancer surgery often 
resulted in undesirable loss of function and deformities; more recently, there has been a 
trend to minimise surgery and to retain as much form and function as possible. A good 
example of this conservative trend is provided by the current therapy for breast cancer. In 
the past, radical mastectomy provided an adequate means of local control; however, the 
consequent effects could involve other organs and were often psychologically traumatic. 
Currently, partial mastectomy (lumpectomy) with adjuvant therapy is favoured because it 
provides a means of control that is as good as that provided by radical mastectomy, 
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without the mutilating effects. The use of imaging techniques to define the size and 
position of deep-seated tumours and their surrounding organs can provide important 
information before surgery and radiotherapy. Such advances have led to an improvement 
in outcome of cancers such as that of the stomach, where surgery is essentially the only 
possible curative treatment [7-9].  
 
The objective of radiotherapy is to deliver a defined radiation dose to a specific tissue 
volume — including the tumour and adjacent tissues where tumour cells might be found 
–with the intent to kill tumour cells while minimizing irradiation of surrounding, healthy 
tissue. Radiotherapy generates DNA strand breaks through free-radical formation. Due to 
its more relevance to the work of this thesis, radiotherapy will be discussed in more detail 
in the next section. 
 
The term “chemotherapy” is conventionally confined to the use of cytotoxic or 
cytostatic drugs that respectively kill malignant cells or prevent them from proliferating. 
The efficacy of such drugs depends on the concentration of the drug reaching the tumour, 
the duration of exposure, and the proportion of the population that is proliferating. The 
latter point is important, as the drugs act mainly on proliferating cells and tumours 
commonly include subpopulations of cells that are not dividing. This action is not limited 
to malignant cells; it affects proliferating cells throughout the body, resulting in numerous 
down-stream effects. Chemotherapy almost inevitably causes depression of the 
haemopoietic system. This means a reduced output of blood cells, which result in reduced 
resistance to disease, anaemia and thrombocytopenia (reduced number of platelets). 
Generally, chemotherapeutic drugs cause severe toxic side effects, e.g., they can 
specifically toxic to vital organs such as the heart and the kidney. So they must be used 
with utmost caution. To some degree, the side effects can be minimised by careful dosing, 
by using combinations of drugs with different toxicities or therapies (combination 
therapy) and by using supportive procedures. During the course of treatment, the target 
cells may become resistant to the drugs used, and so many chemotherapists prefer to use 
high doses initially in the hope of killing all the malignant cells before resistance 
develops [7-9]. 
 
Solid tumours are the most formidable cancer to be cured. In the case of solid tumours, 
the first step is usually surgical removal of the primary cancer together with a margin of 
normal tissues, as such cancers are commonly irregular in shape. Then radiotherapy is 
applied to the area around the site to destroy any possible remnants of the tumour. At the 
same time, cytotoxic drugs can be given to kill residual cancer cells and possible 
metastases. In such circumstances, the secondary treatments are referred to as adjuvant 
therapy; they are not the major modality, but they are an essential supplement to back it 
up. This is the usual pattern of treatment, but there are some situations where alternative 
approaches are used. In regions of anatomical complexicity, such as the head and neck, 
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and in regions of vital biological function, such as the brain and spine, surgery would 
cause many problems, and so radiotherapy is sometimes the preferred modality. In 
disseminated cancers such as leukaemia, the only modality that can be used is 
chemotherapy [7-9].  
 
Photodynamic therapy (PDT) is emerging as a novel clinical approach that uses lasers 
and drugs (photosensitizers) for the treatment of various tumors and other non-malignant 
conditions, such as age related macular degeneration, and has great potential for 
applications in regenerative medicine [11]. PDT has potential advantages over surgery 
and other therapies: it is comparatively non-invasive, can be targeted accurately and has 
fewer side effects. Visible light on its own does not damage cells, but it can have 
deleterious effects in the presence of light-sensitive (photosensitive) chemicals such as 
porphyrins plus oxygen. Naturally occurring porphyrins such as haemoglobin bind and 
transport oxygen (O2). In the laboratory, haemoglobin can be modified with acid so that it 
can absorb light in the 630nm (red) region of the spectrum to provide energy transfer 
from the photosensitive porphyrin to oxygen and generate the reactive superoxide radical 
O2·. The porphyrin is thus a prodrug. Only cells containing porphyrin are directly 
destroyed. Photodynamic therapy has been adapted such that the porphyrin is given 
systemically and the target cancer is illuminated with 630nm light focused on the cancer 
and not the surrounding tissues. The most commonly used photosensitizer is porfimer 
sodium, a partially purified haematoporphyrin derivative. Photodynamic therapy has been 
used successfully to treat cancers of the bladder, head and neck, and oesophagus. 
Currently, most photosensitizers in clinical applications are photoactivated using a light 
source in the range 630-690 nm. At this wavelength, the largest attainable depth of 
PDT-induced cellular changes could reach up to 15 mm, but in most cases it is much less 
than half of that. For this reason, the increase of light penetration is considered to be an 
important factor in increasing the clinical efficacy of PDT. This is one of the focuses of 
current research [11]. 
 
Biological treatment refers to a general concept involving the attempts to treat cancer 
by engaging the body’s own natural systems. Important approaches include strengthening 
the immune defense, stimulating new blood formation, and anticipated opportunities in 
genetic therapy. Although progress in this area has been substantial, these forms of 
therapy can not yet be considered as significant as surgery, radiotherapy and 
chemotherapy [7-9].  
 
In spite of intense studies over decades, the main curative therapy for cancer – surgery 
and radiotherapy — is generally only successful if the cancer is found at an early 
localized stage.  Existing chemotherapeutic treatments are largely palliative in advanced 
tumours. Often chemotherapy is effective only for a certain period of time.  Toxic side 
effects are also a common issue.  These drawbacks have even prompted the call to 
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identify molecular mechanisms of human cancers and to design therapeutics that target 
these mechanisms instead [10].  In the development of new drugs, several issues need to 
be addressed, including improved and durable antitumour efficacy, reduced toxic side 
effects and prevention of drug resistance [10].  However, most of the molecular 
mechanisms of action, toxicity and resistance in existing effective drugs are still poorly 
understood [12, 13].  The tradition approach for anticancer drug discovery is to 
synthesize a large number of drug analogue compounds and then to do bioactivity and 
cytotoxicity screening. It is estimated that more than 10,000 compounds need to be 
screened in order to obtain one new, effective anticancer drug [14].  Overall, the 
identification of successful anticancer agents with clinical utility has remained a 
somewhat empirical process [10].  There is a strong need for a mechanistic 
understanding of action of existing drugs at the molecular level, which can, in turn, lead 





Most therapeutic radiography uses specialised apparatus that delivers a narrow beam of 
high-energy X-rays to a well-defined area of the body. This allows treatment of both 
superficial and deep-seated tumours without surgical trauma. Damage to the adjacent and 
overlying tissues is minimised by selective shielding and by varying the direction of the 
beam so that the total dose occurs only at the site of the tumour and adjacent organs, 
together with the use of stereotactic apparatus and computer-aid planning of irradiation. 
This is important because some organs such as the lens of the eye, the spinal cord, the 
lung, the kidney and the small intestine, have a poor capacity to repair radiation damage 
[7-9].  
 
The desired outcome of radiotherapy is to kill malignant cells by causing irreparable 
damage to their DNA. Cycling cells are radiosensitive, but tumour stem cells or quiescent 
G0 cells are relatively resistant. Because of this issue, radiation doses are fractionated, so 
that the total dose is delivered over a period of days. This allows any damaged normal 
tissues to repair themselves while the tumour stem cells become reoxygenated and start 
proliferating. Subsequent doses will then destroy the reactivated tumour cells. 
Reoxygenation is also important, as oxygen is required for the generation of the free 
radicals necessary to produce full effectiveness (oxygen effect will be discussed in more 
detail below) [7-9]. 
 
Less commonly, radiotherapy involves the use of radio-cobalt sources can be used to 
provide a beam of gamma rays for external radiotherapy. Another application is 
brachytherapy, which uses radiation from radioactive sources either placed closed to or 
inserted in the tumour. Plastic-covered flexible iridium-131 wires can be inserted into 
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tumours of the tongue, breast, brain and buccal mucosa to produce effects similar to those 
produced by external radiotherapy systems [7-9].  
 
In radiotherapy, ionizing radiation is used to kill tumour cells. The principal means by 
which ionizing radiations dissipate their energy in matter is by the ejection of orbital 
electrons from atoms. The removal of one or more of these orbital electrons is called 
ionization. Because each electron is hold within its orbit by a specific binding energy, 
work must be done to when any orbital electron is removed. Atoms are electrically 
neutral, but when they are ionized the loss of an orbital electron leaves them positively 
charged. The ionized atom and the dislodged electron constitute an ion pair [15, 16]. 
 
Not every interaction between ionizing radiation and matter need result in ionization. 
Excitation, a less drastic process than ionization, may also occur. In it an electron in an 
atom is raised to a higher energy state, moved to a more distant orbit, but not ejected. 
Excitation is the most important mode of energy dissipation by ultraviolet light, and 
probably forms a significant percentage of the energy dissipated by ionizing radiation in 
tissue [15, 16].  
 
Ionization produced by radiation is a random process; ordinarily, an ionizing particle 
will have sufficient energy to remove an orbital electron from any atom with which it 
chances to interact. Any atom, without preference, may lose an electron in this way and is 
itself, ionized. The randomness-the nonselectivity of the process is in sharp contrast to 
the action of radiations of low-energy (Ultraviolet) which are absorbed selectively by 
certain molecules and have no effect on others. The transfer of energy from lower-energy 
radiations, unlike that of ionizing radiation, is not random and will occur only with 
certain atoms or molecules, even at times, with a small portion of a molecule [15, 16].  
 
If a complex system (one consisting of more than one kind molecule) is irradiated with 
any of the ionizing radiations, then, because the nature of the energy exchange is random, 
ionization is most likely to occur in those kinds of molecules that are present in the 
largest number. When cells or tissues are irradiated, most of the radiation energy is 
absorbed by water, because cells are made up of more than 70% water. As will be shown 
below, there are essentially three different species formed in the radiolysis of water, the 
OH radical, the solvated electron (eaq-) and the H-atom.  
 
The two major processes of the interaction of ionizing radiation with matter are 
ionization and electronic excitation. In liquid water these reactions are described by 
reactions 1 and 2 [15, 16]: 
 
H2O  H2O+ +e-             (1) 
H2O  H2O*               (2) 
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The water radical cation is a strong acid and rapidly loses a proton to the surrounding 
water molecules (reaction 3). The electron becomes solvated within a very short time 
(reaction 4): 
 
H2O+ + H2O  H3O++OH·       (3) 
e- + n H2O  eaq-               (4) 
 
The excited water molecules formed in the second primary process (reaction 2) can break 
up into H-atoms and OH radicals or form an electron (reaction 5): 
 
              H2O*  H· + OH· or H2O+ +e-               (5) 
 
The free radicals(OH·, and H·) either react with one another within the spur or diffuse into 
the bulk of the solution, reacting with anything that they encounter, producing H2O, H2O2, 
molecular hydrogen and some other free radicals such as HO2·(hydrogen peroxide). The 
major products of water radiolysis are OH•, eaq-, H•, H2O2 and H2, whose yields per 100 
eV energy deposited are 2.4, 2.8,  0.4,  0.8 and 0.4, respectively.  Most importantly, in 
the living system, these free radicals may react with organic molecules-the molecules of 
which cells and tissues are built — and change them. The following equations illustrate 
how this may come about. 
 
HO2·+RH  R·+H2O2                           (6) 
RH+HO2·  RO· (an organic free radical) + H2O     (7) 
 
If RH in either of these cases is a fundamental organic molecule — one important in the 
metabolism of the cell, either as a building block or as a finished product — an upset in 
the chemistry or the metabolism of the cell can be expected. In addition, H2O2 is a cell 
poison and if present in sufficient quantities can materially interfere with metabolism. 
Organic free radicals may represent not only changed molecular constituents of the cell, 
but also substances that are free to attack other constituents and generate further 
molecular changes.  
 
The presence of oxygen during irradiation enhances the magnitude of radiation effects. 
These effects are of sufficient importance to merit special treatment. In the biological 
system, oxygen reacts with the free radicals produced by radiation and draws them into 
further destructive, auto-oxidative chain reactions with the molecules of cells. It is also 
very possible that oxygen can block restoration of an intact molecule by interacting with 
radiation-produced organic free radicals which might otherwise have been restored to its 
normal state. Thus the effect of radiation can also be enhanced by prevention of some 
fraction of the expected restoration. Finally, the presence of oxygen at irradiation will 
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greatly promote the formation of hydrogen peroxide and organic peroxide [15, 16].  
 
The processes described above are the initiating events leading to damage — the 
transfer of energy from ionizing radiation to the substance of the cell (ionization) and the 
subsequent transfer of this energy among the molecules of the substance (free radicals, 
oxygen effect). Follow these initiating events, alternation in structure and function at 
much higher levels of organization is detected at some later time after irradiation of a 
living system.  
 
The basic concept under which there is an application of the oxygen effect in 
radiotherapy rests on the premise that certain tumours have hypoxic (radioresistant) 
regions when compared to normal tissue and even to other regions of the same tumour. 
Even though tumours, with their large numbers of dividing cells, are, in many cases, 
more sensitive to radiation than the more static normal tissues that surround them, regions 
of poor oxygenation within tumours, particularly solid tumours, might make some of the 
cells quite insensitive to radiation — insensitive enough to survive the usual forms of 
radiotherapy.  
 
It has been accepted for a long time that DNA damage and tumour cell death in 
ionizing radiotherapy are caused mainly by OH and H2O2, while electrons would play 
only a minor role.  However, a recent important study has shown that low-energy free 
electrons in energies of 1-20 eV can cause significant DNA damage via formation of 
transient anion resonances [17].  More remarkably, the free radicals produced in 
ionizing radiation need oxygen to produce a full radiotherapy effect, as mentioned above.  
In contrast, the electrons produced in the ionizing radiation have the radiotherapy effect 
without the need of oxygen and thus can play an important role in the hypoxic regions of 
the living system. 
 
Moreover, in order to minimize side effects and enhance radiotherapeutic efficacy, 
radiosensitizing drugs are often used in combination with ionizing radiation.  The 
mechanism for the radiosensitivity enhancement is generally related to the reactions of 
electrons with the sensitizing drugs. The application of radiosensitizers is especially 
beneficial to hypoxic tumours.  
  
 
1.3 Halopyrimidines as radiosensitizing drugs 
 
Halopyrimidines, e.g., bromodeoxyuridine (BrdU) and iododeoxyuridine (IdU), are most 
important hypoxic sensitizers in radiotherapy of cancer. Replacement of thymidine in 
DNA by BrdU/IdU has long been known to enhance DNA damage induced by ionizing 
radation (γ- or x-ray) [18-27]. In 1958, Zamenhof, DeGiovanni and Greer observed that 
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bacterial cells containing DNA in which thymine is replaced by bromouracil (BrU) 
become more sensitive to ionizing radiation than their unsubstituted counterpart [18]. 
This report led to an important application: the treatment of tumors by combining 
incorporation of halopyrimidines into DNA and ionizing radiation. Since then, much 
work has been devoted to understanding the mechanism by which these radiosensizers 
operate [19-27].  
 
Incorporation into DNA is a prerequisite for radiosensitization of human tumors by the 
halogenated thymidine analogues, and the extent of radiosensitization correlates directly 
with the percentage of thymidine substitution in DNA [25, 26]. Halogenated pyrimidine 
analogues are incorporated into actively dividing cells and substitute for thymidine in 
DNA. As a result of thymidine substitution in DNA, tumor cells are more sensitive to the 
lethal effects of radiation. The sensitivity to irradiation of cells that have incorporated 
(BrdU) increases about two to three times [27].  
 
Also, replacement of thymine in DNA by BrdU/IdU has long been known to enhance 
photosensitivity with respect to single- and double-strand breaks, creation of alkali-labile 
sites and DNA-protein photo-cross-linking, by forming uracilyl radical [28-29]. The 
enhancement of DNA damage caused by UV-irradiation of duplex containing BrdU/IdU 
has received considerable attentions, and it was observed that the BrdU/IdU enhanced 
DNA damage shows significant nucleic acid sequence dependence [29, 30].  
 
In addition, halopyrimidines have also been exploited to probe protein-nucleic acid 
interactions and nucleic acid structure via inducing DNA/RNA-protein photocrosslinking 
[34-37]. The results reported by Tad H. Koch and coworkers demonstrated that 
site-specific substitution of certain nucleotides with BrdU/IdU greatly increased the 
photo-cross-linking yield and substitution favoring a specific protein-DNA cross-links 
[36, 37]. The ability of BrdU/IdU and other 5-halopyrimidine nucleosides to form 
protein-nucleic acid cross-links has been exploited for mapping protein-nucleic acid 
interactions [34-37]. The 5-halopyrimidine nucleosides’ sensitivity to UV-irradiation has 
been exploited in the application of these molecules as structural probes of 
protein-nucleic acid interactions and nucleic acid structure [34-37].  
 
Identified as a potential sensitizer for radiotherapy of cancer, halopyrimidines have 
been tested in several Phase I - III clinical trials [38-40]. Some clinical studies have 
demonstrated the ability of BrdU to radiosensitize malignant brain tumors [38]. The 
result of recent phase I-II clinical trials using infusion of BrdU or IdU before and during 
radiation therapy suggest an improved outcome compared to radiation alone [39]. 
However, Phase III clinical trials failed [40]. Generally the clinical results have not been 
satisfactory and therefore no XdUs have been approved for clinical use.  This is 
probably due to poor understanding of the mechanism of the radiosensitivity 
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enhancement. Although lots of investigations dedicated to the understanding of the 
mechanism(s) by which these halopyrimidines operate, the molecular reaction 
mechanism of these drugs in their early physio-chemical steps is still poorly understood.  
 
 
1.4 The major objectives of this thesis 
 
The major objective of the proposed work in this thesis is to obtain a mechanistic 
understanding at the molecular level of halopyrimidnes as the most important hypoxic 
radiosensitzing drugs, using the advanced time-resolved femtosecond laser spectroscopy. 
Real-time observations of how the molecular reactions of halopyrimidines lead to the 
formation of reactive radicals should provide important information for a mechanistic 
understanding of these anticancer drugs leading to the radio-/photo-sensitization 
enhancement.  This understanding has the great potential to improve therapeutic effects 
of these drugs.  Moreover, with the knowledge, it will be possible to design new drugs 




1.5 Structure of this thesis 
 
Following this introduction, the principle of time-resolved femtosecond (fs) laser 
spectroscopy is described in chapter 2. Chapter 3 gives a description of direct observation 
of the transition state of ultrafast electron transfer reactions of BrdU with the prehydrated 
electron. In chapter 4, the experimental results for the studies extending to four 
halopyrimidines including FdU, CldU, BrdU and IdU are presented and the reaction 
mechanism for the radio-/photosensitization is addressed, together with a discussion on 
the physical nature of the prehydrated electron. Then the reaction transition states of 
prehydrated electrons with nucleotides is shown and discussed in chapter 5. Finally, the 
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The major methodology to be applied for this project is time-resolved femtosecond (fs) 
laser transient absorption spectroscopy. This is the most versatile and powerful technique 
for real-time observation of molecular reactions and can be described as the world's 
fastest “camera” [1].  
 
A schematic diagram to illustrate the principle of a fs-resolved laser spectroscopy is 
shown in Figure2.1. It uses laser flashes of such short duration that we are down to the 
time scale on which the reactions actually happen - femtoseconds (fs) (1fs= 10-15 
seconds). The “camera” records what happens in a molecular reaction by initiating the 
reaction with a femtosecond laser pulse (pump pulse) in a certain color (wavelength) (the 
reactant molecule is excited into a higher energy state). A short time later a second pulse 
(probe pulse) in a different color takes a “picture” of the reacting molecules or the newly 
created species.  By successively delaying the probe pulse a “film” is obtained of the 
course of the reaction.  The “camera” gives no direct image of the molecules. Instead, the 
reacting molecules or new species are observed by measuring certain characteristic 
properties, e.g., an optical transmission (an absorption spectrum is obtained).  The one or 
more transition states probed (detected) at chosen wavelengths (colors) have specific 
spectra that serve as fingerprints, and they can therefore be identified and characterized. 
 
Dr. Lu has successfully built a high-sensitivity time-resolved fs laser spectroscopy 
laboratory in the Department of Physics of the University of Waterloo. Our fs laser 
amplifier system produces a highly stable laser beam of 1 kHz, 1mJ per pulse and <120 fs 
pulse width. This amplifier system is accompanied by two optical parametric amplifiers 
(OPAs), which offer a wide wavelength extension from UV (≥266 nm) to NIR (several 
um) for the pump and the probe pulses.   
 
In our applications, the pump pulse is used to initiate the reaction or to create a 
reacting species such as an electron via two-photon excitation of water, while the probe is 
to detect the intermediate species (transition states) during a reaction, which include a 
precursor electron, a drug excited state and a drug anionic state formed after capturing an 
electron.  The time delay between the pump and the probe pulses is obtained by a precise 
microstepping motor stage, and time resolution in fs can therefore be achieved with the 
use of fs laser pulses (not a long detour needed: the light goes through the distance of 1 
µm in 3.3 fs!). The electronics recording the spectrum and the motion controller are 
integrated into a Labview program that directly gives rise to a transient absorption or 
fluorescence spectrum (as a function of delay time) to show the real-time evolution of a 
particular transition state.  Once intermediate species are identified, the reaction pathway 
can be determined.  With this information, it is then possible to predict, understand and 
modify the course of a drug reaction [1-3].  This spectroscopic technique provides us 
with a unique capability of obtaining real-time observation and control of biochemical 







Figure 2.1. Schematic diagram for a fs time-resolved laser spectroscopy 
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Figure 2.2. High-sensitivity time-resolved femtosecond laser transient absorption spectra of the 
dynamics of an excited state of a candidate PDT drug (indocyanine green, ICG), where the used 
pump and probe pulse energies are only 12 and 0.2 nanojoule (nJ), respectively. 
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Currently, the spectroscopy at our laboratory can detect transient absorbance of as 
small as 10-4 of an intermediate reaction species at the very low pump energy of ≤50 
nanojoule (nJ) and the very low probe energy of ≤1 nJ with a time resolution of 20 fs. 
This is essential to the studies of biomolecules with ultrashort fs laser pulses, where both 
damage to sample and secondary reactions can be avoided and therefore true initiated 
reactions of intact drug molecules can be observed in real time.  
 
A typical spectrum is given in Figure 2.2, where the first fs pulse (the pump) at 800 nm 
was used to excite a candidate PDT drug (ICG) molecule and the second pulse (the 
probe) at 480 nm coming at varying time delay was used to detect one of the simplest 
transition states, an excited state (ICG*) of the drug.  The dynamics of the transition state 
can be determined by measuring the decaying lifetime of the species.  If there was present 
another agent, e.g., cisplatin (CDDP), showing reactivity to ICG*, then electron transfer 
(ET) from ICG* to CDDP is expected and the decay dynamics of ICG* would be 
changed.  By measuring the variation in the lifetime of ICG* as a function of CDDP 
concentration, we can determine the reaction efficiency (the rate constant).  Moreover, a 
third species can be introduced into the ET reaction, which could promote or quench the 
ET reaction. Thus, we can monitor the mediating effect of the third agent.  
 
To obtain the precise formation and decay lifetimes of transition-state species, the 
instrument response function must be taken into account to fit the obtained transient 
absorption spectra.  The time-dependent transient absorption signal is given by a number 
of exponential functions. These exponential terms are convoluted with the instrument 
response function repressed by a Gaussian function )2/exp()2/1()( 22 σσπ ttG −= , 
where σ is the standard deviation for the Gaussian and is related to the FWHM (Full 
Width at Half Maximum) of the pump-probe cross-correlation function 
by 2ln22/FWHM=σ . The resulting time-dependent signal S(t) is given by  
 










                           (2.1) 
 
where negative (positive) ci is the amplitude of the component i with rising (decay) time 
τi.  Eq. (2.1) can be solved analytically to give the following equation [4]: 
 

















            (2.2) 
 
where erf is the error function. The best fits to the experimental spectra were obtained by 












1. Cited from The Royal Swedish Academy of Sciences’ illustrated presentation for 
The 1999 Nobel Prize in Chemistry 
(http://nobelprize.org/chemistry/laureates/1999/illpres/reaction.html). 
2. J. C. Polanyi, “Some Concepts in Reaction Dynamics (Nobel Lecture)”, Science, 236, 
680(1987). 
3. A. H. Zewail, “Femtochemistry: Atomic-Scale Dynamics of the Chemical Bond 
Using Ultrafast lasers (Nobel Lecture)”, Angew Chem. Int. Ed., 39, 2586(2000); J. 
Phys. Chem. A, 104, 5660(2000). 




Direct observation of the transition state of ultrafast electron 





























Real-time observation of the transition state in a chemical reaction is of great interest, 
since it is important to know the properties of the transition state if one is to predict, 
understand and modify the course of a reaction [1].  The application of time-resolved 
femtosecond laser spectroscopy to the studies of transition states led to the birth of a new 
field in chemistry called femtochemistry [2], which has quickly developed into another 
new field called femtobiology in the past decade.  Electron transfer (ET) underlies many 
reactions in chemical, biological, physical and environmental systems [3-8]. 
 
Replacement of thymidine in DNA by halopyrimidines such as bromodeoxyuridine 
(BrdU, Scheme 1) and iododeoxyuridine (IdU) has long been known to enhance DNA 
damage and cell death induced by ionizing radiolysis and UV photolysis [9-13]. 
Moreover, halopyrimidines have also been exploited to probe protein-nucleic acid 
interactions and nucleic acid structure via inducing DNA/RNA-protein photocrosslinking 
[14-16]. Identified as a potential sensitizer for radiotherapy of cancer, BrdU has been 
tested in several Phase I - Phase III clinical trials [17-19].  Generally the clinical results 
have not been satisfactory and therefore BrdU has not been approved for clinical use.  
This is probably due to poor understanding of the mechanism of the 
radio-/photosensitivity enhancement [20]. It is generally believed that the first and critical 
step involved in the action of BrdU is the dissociative electron attachment (DEA) to 
BrdU, leading to the formation of an anion and a highly reactive radical dU•: e− + BrdU 
→ BrdU*− → Br− + dU• [20, 21]. This seems reasonable, since halogen (chlorine, 
bromine and iodine) containing molecules are well known to have extremely large DEA 
cross sections at electron energies near zero eV, as seen by Abdoul-Carime et al. [22].  
However, the origin and the nature of the electron responsible for this ET reaction in  
 
Scheme 1. Chemical structure of BrdU 
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radio-/photosensitization of BrdU are not well known, and different mechanisms were 
proposed in the literature.  In UV sensitization with BrdU, it was suggested that the 
reaction involves an ET from a neighboring DNA base (adenine) [11-13], while in 
radiosensitization it was proposed that the electron involved in the ET reaction is a 
solvated (hydrated) electron (ehyd−) as a result of radiolysis of water in biological 
environments during ionizing radiation [20, 21]. 
 
The hydrated electron (ehyd−), having an absorption band in the visible light peaking at 
720 nm, is a well-known product in ionizing radiation of a biological system; a great deal 
of information is known about the hydrated electron and its chemistry [23].  It is 
generally accepted that the hydrated electron is responsible for bond breaking in halogen 
(Cl, Br or I)-containing compounds to form halogen ions. With the advent of 
time-resolved femtosecond laser spectroscopy, however, the solvation (hydration) 
dynamics of an excess electron, e.g., produced via two-UV-photon excitation in water, 
has been studied in certain details [24-27]. As shown in Figure 3.1, electron solvation is 
now known to occur essentially through two major stages: before becoming fully 
solvated, the electron is localized in a weakly-bound preexisting trap and is called a 
precursor to the hydrated electron, denoted as epre− hereafter, with a lifetime <1 ps [24-27].  
A more recent study by Laenen et al. [28] has shown evidence for multiple precursor 
states with lifetimes of 110 fs, 200 fs and 540 fs, respectively, which have absorption in 
the wavelength range from NIR to IR (µm).  It has been proposed that epre− is 
responsible for the large enhancements in electron-induced bond breaking of halogenated 
molecules such as chlorofluorocarbons (CFCs, environmentally important 
ozone-depleting substances) adsorbed on water ice, which is relevant to the formation of 
the ozone hole in earth’s atmosphere [29-32]. This is probably related to the fact that the 






















Figure 3.1. Femtosecond salvation dynamics of electrons in water. 
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and I)-containing molecules near zero eV. However, the role of prehydrated electrons on 
electron-driven processes involving molecules in aqueous environments is generally poor 
understood and is relevant to several critical issues facing environmental scientists and 
radiation biologists (see, e.g., a recent review in ref. 8).  Direct observation of the ET 
between epre− and halogenated molecules is thus of great interest; it has been difficult and 
not yet been obtained, because of the ultrashort lifetimes of epre−, on the femtosecond time 
scale. Previous nanosecond (ns) pulse radiolysis experiments on BrU showed a transient 
absorption peak at ~330 nm, which was attributed to the transition state BrU*− [21].  
But without a fs resolution it was impossible to observe the formation of the real 
transition state and therefore to determine which species, whether epre− or ehyd−, leads to 
the reaction. Using fs-resolved laser spectroscopy, Lu et al. [33] recently investigated the 
possible reaction of epre− with BrdU. In those experiments, a reduction the epre− signal was 
initially observed, but it was due to the absorption of the 266 nm pump pulse by BrdU.  
BrdU absorption has peaks at 267 nm and 279 nm and extends up to 315 nm. At low 
BrdU concentrations, any true reduction in the epre− signal would indicate ultrafast 
long-range electron transfer [33]. After avoiding the direct absorption by BrdU, the 
results showed no such a reduction in the electron signal and thus no such a long-range 
ET reaction. However, it is still possible to observe the short-range reaction of epre− with 
BrdU by directly detecting the formation of the transition state, BrdU*−. Herein, we 
report the first real-time observation of the transition state of the ultrafast ET reaction of 
BrdU with the precursor electron (epre−). 
 
 
3.2 Experimental details 
 
The methodology for pump-probe femtosecond transient absorption measurements in 
the Waterloo’s laboratory is similar to that was described previously (6, 29). We used a 
Ti:sapphire laser system producing 120 fs, 1mJ laser pulses centered at λ=800 nm at a 
repetition rate of 1 kHz, two optical parametric amplifiers producing pump and probe 
pulses with wavelengths from visible to infrared. Alternatively, a femtosecond tripler was 
used to produce a 266 nm pulse.  The polarization of pump and probe pulses was set at 
the magic angle (54.7°) to avoid contribution from polarization anisotropy due to 
orientation motions of molecules. A small pump pulse energy (≤0.3 µJ) was used to make 
the solvated electron signal negligible when detected at (probe) wavelengths around 330 
nm and to avoid any nonlinear effects.  The sample was held in a 5 mm cell with a 
stirring bar to avoid any photoproduct accumulation.  Ultrapure water with a resistivity 
of > 18 MΩ/cm was used and BrdU from Sigma-Aldrich was used as supplied. The 
purity / concentrations of BrdU were checked / calibrated by static absorption spectra of 
the BrdU, measured with a UV/Visible/NIR spectrophotometer (Beckman, life sciences). 
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3.3 Results and discussion 
 
Figure3.2 is a plot of the measured static absorption spectrum of a fresh sample of 0.44 
mM BrdU in water in a 5-mm quartz cell; the concentration calibration curve was 
obtained with our measurement of the BrdU extinction coefficient (α=8790 M−1cm−1 at 
279.5 nm) . 
 
Figure 3.2. (Left) Static absorption spectrum of 0.44 mM BrdU in water; (Right) The absorbance 
at 279.5 nm as a function of BrdU concentration in a 5-mm cell.  
 
 
Our pump-probe fs-resolved experiments were first conducted with the excitation (pump) 
wavelength at 266 nm and the detection (probe) at 330 nm to measure the transition 
species BrdU*−.  With λpump=266-320 nm, the 2-photon excitation mechanism for 
electron generation in water was verified by the measured quadratic dependence of the 
transient absorption intensity of epre− / esolv− on the pump power. For BrdU solutions, a 
strong signal in the transient absorption spectrum is indeed observed, as shown in Figure 
3.3. However, the decay of the signal is quite rapid on a subpicosecond scale and 
superposes on a slow component. The best fit to the data gives three lifetimes: a rapid 
decay with τ1 = 0.4±0.1 ps, a long tail with τ3 in ns, and an immediate τ2 with a larger 
uncertainty. Measuring the spectra carefully with varying the pump power, we observe 
that the intensity of the signal peak at 0.2 ps does not show a quadratic but a linear 
dependence on the pump power (the inset in Figure 3.3), while the absorbance in the long 
tail does show a quadratic dependence. This indicates that at least two species contribute 
to the signal and the rapidly decaying signal results from one single photon process and 
not from the electron generated by the two-photon excitation process.  Therefore the 
rapidly decaying species cannot be due to the transition state BrdU*−.  Moreover, there 
is essentially no rising time in the signal considering the total instrument response  


















































































 Pump Power (uJ)
 
Figure 3.3. Femtosecond transient absorption spectrum of 5 mM BrdU in water, pumped at 266 
nm and probed at 330 nm. The solid line is the best fit to the experimental data (solid squares). 
The inset is the peak absorption at 0.2 ps as a function of pump power. 
 
function of 0.2-0.4 ps [33]. This fast component can be explained as due to the excited 
state BrdU* resulted from the absorption of 266 nm photons by BrdU [33]. It is therefore 
most likely that the rapidly decaying species is the BrdU* that has also strong absorption 
at 330 nm, while the signal associated with the transition state BrdU*− is weaker because 
of its involvement of the two-photon excitation and is buried in the stronger BrdU* 
signal. 
 
To avoid the absorption by BrdU, we varied the pump pulse wavelength λpump to 318 
nm while keeping the probe pulse wavelength λprobe at 330 nm.  The results are plotted 
in Figure 3.4a. Since the wavelengths of the pump and probe pulses are now close to each 
other, a coherent ‘spike’ appears at the time zero, which is most clearly seen in the 
spectrum for the pure water.  The ‘spike’ shape depends sensitively on the overlapping 
geometry and the focusing of the pump and the probe beam. For wavelengths ≥315 nm, 
the absorption of BrdU is negligible, as seen in the UV-vis spectrum [33].  The result 
now shows that the rapidly decaying species due to BrdU* disappears in the spectra and 
there is a clear rising in the signal that peaks at ~0.55 ps.  The transient absorption 
spectra simply exhibit a linear dependence on BrdU concentration in the measured range 
of 0.1 to 31 mM. This indicates that the transient absorption signal does result from the 
BrdU molecules. By subtracting the transient absorption spectrum for the pure water 
from those of BrdU, the ‘spike’ can be removed nearly completely from the spectra, as 
 24
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Figure 3.4. Femtosecond transient absorption spectra of BrdU in water, pumped at 318 nm and 
probed at 330 nm: (a) original data, where the sharp peak at time zero is the coherence “spike” 
observed when λpump and λprobe are close to each other; (b) spectra obtained after the subtraction of 
the spectrum for the pure water. The solid lines in (b) are the best fit to the experimental data, 
giving a rising time τ1=0.15 ps and two decay times shown in Figure 3.4b.   
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shown in Fig. 3.4b.  This subtraction makes it possible to make a theoretical fit to the 
experimental spectra, and hence the formation and decay times of the transient species 
can be quantitatively obtained.  From the fits using Eq. (2.2) in Chapter 2, we obtain a 
formation time of ~150±50 fs and two decay times: one is of ~1.5±0.3 ps and the other in 
the scale of ns.  The ns decaying component seems consistent with the result observed in 
previous ns pulse radiolysis experiments [21].  Moreover, the yield of the transient 
absorption at 330 nm now shows a quadratic dependence on the pump pulse energy, as 
shown Figure 3.5.  The possibility to attribute this transient absorption to the BrdU** 
state produced via 2-photon excitation of BrdU can be ruled out by the observation that 
no transient absorption signal can be detected as the pump wavelength is ≥400 nm, while 
the 2-photon excitation cross section of BrdU has maxima at 534 nm and 558 nm [33].  
These results indicate that the transient species detected in the present experiments must 
originate from the electrons generated via two-photon excitation of H2O molecules.  
Furthermore, the transient absorption spectra were also measured with varying probe 
wavelengths while keeping λpump at 318 nm.  The results are plotted in Figure 3.6, 
showing that the transient species has indeed an absorption peak at 330 nm.  This 
observation of the absorption peak similar to that detected in ns resolved radiolysis 
demonstrates that the transient species observed in ns resolved experiments evolves from 
the short-lived species revealed in current fs experiments. 
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Figure 3.5. Femtosecond transient absorption spectra of 10 mM BrdU in water, pumped at 
318nm with various pulse energies and probed at 330nm, after the subtraction of the spectrum for 
the pure water. The inset is the square root (SQR) of the absorbance peak intensity at 0.55 ps 
versus pump pulse energy. 
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Figure 3.6. Femtosecond transient absorption spectra of 10 mM BrdU in water, pumped at 318 
nm and probed at various wavelengths, after the subtraction of the spectrum for the pure water. 
The inset is the normalized peak transient absorbance A at 0.55 ps versus probe wavelength, 
where A=[A(0.55 ps)-A(8ps)]/A(8ps). 
 
 
One might also consider the possibility that the time-resolved transient absorption 
spectra peaking at ~0.55 ps shown in Figures 3.4-3.6 be due to the signal of the solvated 
electrons that might be generated by BrdU. However, this speculation is clearly 
inconsistent with the following facts. First, BrdU is a well-known strong electron 
scavenger under either ionizing or UV radiation and is therefore explored as a 
radio-/photo-sensitizer [9-13]. Second, BrdU have no considerable absorption at 320 nm 
(see Figure 3.2) and thus there is no basis for BrdU to produce electrons. Third, the 
transient absorption spectra for BrdU shown in Figures 3.4-3.6 are drastically different 
from that for solvated electrons, whose signal is negligibly small for probe wavelengths 
≤350 nm but detectable with an extremely low noise level in the spectrum (as magnified 
by 3 times in Figure 3.4a). The signal of esolv− detectable at various visible wavelengths 
shows a slow rising time of about 1 ps and almost no decay in the first two ps, reported 
widely in refs. 24-28 and ref. 33 and repeated in Figure 3.4a.  Fourth, esolv− has a light 
absorption peak at ~720 nm [23], which differs drastically from the observed absorption 
peak at 330 nm for the transient species associated with BrdU (Figure 3.6).  These facts 
and results lead to a conclusion that the transient absorption peaking at 330 nm must be 




The present fs-resolved results reveal novel features of the formation and decay of 
BrdU*−.  First, the present results demonstrate that BrdU*− forms rapidly within 200 fs 
after the electronic excitation.  Second, the ns-resolved experiments suggested that the 
transient species would have a lifetime of ~7.0 ns [21].  Generally, however, DEA takes 
place in a time scale close to the vibration period of a molecule, which lies in the range of 
10-12 s (ps) to 10-15 s (fs) among molecules.  Beyond this, the transition state of the 
molecule either has dissociated into fragments or has relaxed into a nondissociative 
anionic state.  Indeed, the lifetimes of transient (AB*¯) states of many halogenated 
molecules (ABs) are measured to be in the range of 0.1 to several ps [34]. Thus, it is 
reasonable to assign the faster decay of 1.5±0.3 ps to the dissociation of BrdU*− into Br− 
and dU•.  It is not surprising that the ns resolved experiments could not reveal the rapid 
formation and the fast decay in the time scales from fs to ps of the transient state. 
      
The ns slow decaying can be attributed to the relaxed, nondissociative BrdU− following 
the dissipation of the vibrational energy in BrdU*−.  We have confirmed the above 
assignments of the faster decay of 1.5±0.3 ps to the dissociation of BrdU*− into Br− and 
dU• and of the ns slow decay to the nondissociative BrdU− state by conducting similar 
measurements with another halopyrimidine FdU.  The results to be shown in next 
Chapter shows that no signal for the transition state of a 1.5 ps decay time but only a 
weak ns-decay signal (FdU−) is observed for FdU, in good agreement with the fact that 
the electron attachment to FdU is endothermic and no dissociation occurs for attachment 
of electrons with energies ≤ 3.0 eV [22], certainly for the weekly bound precursor 
electrons (below zero eV).  
   
The present observation of the rapid formation of BrdU*− on a time scale of ≤0.2 ps is 
of particular significance, which clearly demonstrates that this transition species does not 
result from the fully solvated, well-bound electron (esolv−), which would be generated in 
later stages ≥1.0 ps.  Only can the precursor electron, epre−, result in the formation of the 
transient species in such a short period of time following the electronic excitation. In 
other words, the present results provide a direct observation of the ultrafast electron 
transfer reaction involving epre−, that leads to the formation of the transient BrdU*−. 
 
 
3.4  Conclusions 
 
In summary, we report the first real-time observation of the transition state of the 
ultrafast ET reaction of the precursor to the hydrated electron with a biologically 
important halogenated molecule, BrdU as a radio- and photo-sensitizer in cancer therapy.  
Our time-resolved fs laser spectroscopic results show that the ET reaction with BrdU is 
completed within ~0.2 ps after the electronic excitation event, which clearly shows that it 
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is epre−, rather than esolv−, that leads to the reaction. The mechanism revealed here, an 
ultrafast ET followed by dissociative electron attachment of the precursor electron to 
BrdU (epre− + BrdU → BrdU*− → Br− + dU•), will work for not only the 
radiosensitization but the photosensitization of BrdU, since epre− is a universal product in 
both ionizing and UV photon radiation. Moreover, the significance of the present results 
can be extended to understanding of the role of water in electron-initiated processes of 
molecules in aqueous environments and the subsequent radical chemistry, which is 
significant in such diverse fields as stratospheric ozone depletion, waster remediation and 
environmental cleanup, nuclear reactors, radiation processing and medical diagnosis and 
therapy [8]. As the present results show, nonequilibrium precursor electrons may play a 
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Molecular Reaction Mechanism of Halopyrimidines as 
Radiosensitizing Drugs and the Physical Nature of the 







































As described in last Chapter, our time-resolved femtosecond laser spectroscopic study of 
the molecular reaction mechanism of BrdU as a radiosensitizing drug has revealed that it 
is the ultrafast electron transfer (UET) reaction of BrdU with a short-lived, weakly-bound 
precursor electron (epre−), rather than with the deeply-trapped (well-bound) hydrated 
electron (ehyd−), that is responsible for the radical formation from BrdU [1].  In the 
present work, we extend this study to all four potential radiosensitizers XdUs (X=F, Cl, 
Br and I). In gas-phase experiments, Abdoul-Carime et al. [2] have found that halouracils 
(XUs) have extremely large dissociative electron attachment (DEA) cross sections at 
thermal electron energies near zero eV.  However, they showed that the efficiency for 
the uracilyl radical formation by DEA of 0-3 eV electrons is in the order of BrU>ClU>IU, 
while the efficiency for the halogen atomic radical is ClU>BrU>IU, thus concluding that 
ClU should be the most effective radiosensitizer among halouracils. This conclusion 
seems inconsistent with the observations of the biological and therapeutic effects of 
halopyrimidines, which have so far shown that only IdU and BrdU are the most effective 
radiosensitizers [3-14], and with the theoretical calculations by Li et al. [15, 16] that have 
showed the DEA efficiency of BrU≥ClU>>FU.  
 
Moreover, halopyrimidines (particularly IdU, Scheme 1) will be employed as 
quantum-state-specific molecular probes to reveal the lifetimes and physical nature of the 
non-equilibrium precursors to the hydrated electron.  Since the advent of fs laser 
spectroscopy in the late 1980s, the existence of epre− in bulk water or water clusters has 
been studied both experimentally and theoretically [17-33]. In bulk water, the hydrated 
electron es− is believed to be confined in a small cavity and to occupy a s-like ground 
state at ~−3.2 eV from the vacuum level [17, 23, 30].  The absorption of es− peaks at 1.7  
 
 
Scheme 1. Chemical Structure of IdU 
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eV (~720 nm) and can be thought of as a transition from the ground state to a p-like 
excited state at ~−1.5 eV, in analogy to the electronic structure of a hydrogen atom [23, 
30].  Quantum molecular dynamics (MD) simulations by Rossky and co-workers [19] 
have concluded that epre− is a p-like excited state and has a lifetime of ~1.0 picosecond (ps) 
(1ps=10−12 s).  Jay-Gerin and co-workers [21, 22] have proposed that epre− is an electron 
localized at a preexisting trap related to the Urbach tail extending below the water 
conduction band.  Fs laser spectroscopic studies have reported various epre− lifetimes of 
50 fs, ~200 fs, ~540 fs and ~1 ps [18, 20, 24-29].   In particular, Long et al. [20] have 
observed a two-state model with lifetimes of 180 fs and 540 fs for the precursors. Laenen 
et al. [25, 26] have shown clear evidence for the existence of consecutive precursor states 
with lifetimes of 110 fs, 200 fs and 540 fs, respectively, which have absorption peaks at 
2900 nm, 1600 nm and ~900 nm, following two-UV-photon excitation of H2O. 
Kambhampati et al. [27] have also shown the existence of various precursor states of ~50 
fs, 200~300 fs and 400 fs depending on the initial state of the electron in water. Long et al. 
[20] attributed the epre− of a 540 fs lifetime to the so-called wet electron that is really an 
electronically excited state of ehyd−, consistent with the theoretical prediction by Rossky 
and co-workers [19]. In contrast, Laenen et al. [26] attributed both the “wet electron” of a 
540 fs lifetime and the epre− of a ~200 fs lifetime to the (s-like) ground-state electrons 
embedded in hot solvation shells. Kambhampati et al. [27] attributed the 200 fs to be the 
lifetime of the epre− electron located in preexisting traps in water after two UV photon 
excitation of water. Also, Kambhampati et al. [27] and Pshenichnikov et al. [28] have 
attributed the lifetime of ~50 fs to the p-excited state of the hydrated electron and all the 
precursors with lifetimes longer than 50 fs to the s-like ground state in their three-pulse 
experiments. In latter experiments, the hydrated electron was first prepared by a high 
intensity UV pulse followed by pump-probe detection of the excited-state dynamics of 
the hydrated electron.  The attribution of the 50 fs process to the lifetime of the 
p-excited state seems to be supported by some recent anionic water cluster experiments 
[31, 32].  However it is still an open question as to whether the cluster observations can 
be extended to the bulk properties of liquid water [33].  From the above facts, it is 
reasonable to conclude that there have been significant controversies about the physical 
natures of the epre− states in water. 
 
       
4.2 Experimental details 
 
The standard methodology for pump-probe fs transient absorption measurements has 
been described in Chapter 2. We used a Ti:sapphire laser system producing 120 fs, 1mJ 
laser pulses centered at λ=800 nm at a repetition rate of 1 kHz, two optical parametric 
amplifiers producing pump and probe pulses with wavelengths from visible to infrared. 
The polarization of pump and probe pulses was set at the magic angle (54.7°) to avoid 
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contribution from polarization anisotropy due to orientation motions of molecules. To 
avoid the direct absorption of the pump pulse by halopyrimidines, a pump wavelength 
≥320 nm was used in these experiments and excess electrons are produced by a 
two-photon excitation process in water [1, 29].  The probe wavelengths around 330 nm 
were selected to search the transition states (XdU*−) of the reactions of epre− with XdU 
(X=F, Cl, Br and I) [1]. A small pump pulse energy (≤100 nJ) was used to make the 
solvated electron signal negligible when detected at (probe) wavelengths around 330 nm 
and to avoid any nonlinear effects.  Since the pump and probe wavelengths are now 
close to each other, a coherent ‘spike’ unavoidably appears at delay time zero, which is 
clearly seen in the spectrum for the pure water.  This “unwanted” spike, however, offers 
not only a visible and reliable in-situ reference for the pump-probe delay time zero but 
the instrument response function. In our experiments, an instrument response function of 
300 fs was directly given by the full width at half maximum (FWHM) of the coherent 
spike.  Transient absorption spectra of XdU*− are corrected by subtracting the spectrum 
of the pure water from the collected spectra; this also significantly reduces or completely 
removes the coherence spike from the spectra. 
  
To obtain the precise formation times and the lifetimes of XdU*−, the instrument 
response function must be taken into account to fit the measured transient absorption 
spectra. As mentioned in the Introduction, several precursor states to the hydrated 
electron are known to exist in time sequence for electron hydration in water [18, 20, 
24-29].  If two consecutive precursor states react with XdU to form XdU*−, there will be 
two consecutive contributions to the XdU*− signal, that is, the rising and decay of the 
XdU*− signal resulting from the second precursor state will occur with a time delay ∆t 
relative to the formation and decay time of the first precursor. Since the formation time of 
the first precursor is very short, it can approximately be neglected. Thus, ∆t≈τ1, which is 
the lifetime of the first precursor state, i.e., the first rising time of the XdU*− signal.  
Then, the time-dependent XdU*− signal is given by, 
 
)()()( 121 τ−+= tStStS .      (4.1) 
 
Here, S1(t) and S2(t-τ1) are given by Eq. (2.2) in Chapter 2, respectively.  The best fits to 
the experimental data were obtained by using a least-squares fitting program. In our fits, 
the time zero and the FWHM (=300 fs) of the pump-probe cross-correlation function are 
not adjustable fitting parameters, but are fixed at the values determined by the coherent 
spike appearing in the pure water spectrum.  This procedure should give rise to more 
reliable fitted results. 
 
All measurements are conducted at room temperature. The sample was held in a 5 
mm cell with a stirring bar to avoid photoproduct accumulation.  Ultrapure water with a 
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resistivity of >18 MΩ/cm was obtained from an ultrapure water system (Barnstead).  
Halopyrimidines from Sigma-Aldrich were used as supplied and their concentrations are 
calibrated by taking static absorption spectra from a UV/visible spectrophotometer 
(Beckman).  Except for IdU that has a saturation concentration of ~4.0 mM at 300 K, all 





Femtosecond transient absorption spectra of XdUs obtained with λpump=320 nm and 
λprobe=330 nm are shown in Figures 4.1a and 4.1b, together with the spectrum for the 
pure water. The transient absorption spectral intensity as a function of probe wavelength 
with the same pump wavelength is shown in Figure 4.2.  Indeed, the transient absorption 
exhibits a peak around 330 nm for all XdUs, consistent with the earlier observation for 
BrdU described in last Chapter and in reference [1].  This result indicates that there  
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Figure 4.1. Transient absorption spectra of 3.6 mM IdU, 25mM CldU and 25 mM FdU, obtained 
with the pump and probe wavelengths of 320 nm and 330 nm, respectively, after the subtraction 
of the spectrum for the pure water, in the delay time ranges of -1 to 3 ps (a) and -2 to 12 ps. The 
sharp peak at time zero is the coherence “spike” observed when λpump and λprobe are close to each 
other. The solid lines in red in the spectra for BrdU and CldU are the best fits to the experimental 
data, giving a rising time τ1 = 0.15 ps and two decay times τ2=1.5 ps and τ3 in ns. 
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Figure 4.2. Transient absorption intensity of IdU, BrdU, CldU and FdU as a function of probe 
wavelength in the range of 325 to 400 nm with the pump wavelength fixed at 320 nm. The 
absorption intensities are normalized to those at the probe wavelength of 330 nm. The solid line 
in red is an aid to eye. 
 
exists only a single transition state XdU*− of the precursor electron transfer reaction with 
an XdU.  In last Chapter, we have shown that the transient absorption spectra for BrdU 
have a linear dependence on BrdU concentration in the range of 0.1-30 mM [1]; this 
linear dependence has now been reconfirmed for other XdUs, as shown in Figure 4.3 for 
IdU. Thus, higher XdU (X=Br, Cl and F) concentrations were used to obtain the signal 
intensities comparable with that for IdU in Figure 4.1. The spectrum for FdU exhibits no 
considerable transient absorption peak in the first ps after the pump excitation, indicating 
that essentially no DEA of any weakly bound epre− to FdU could occur.  Instead, only 
was an extremely weak, flat (long-lived) signal observed for FdU, which can be 
attributed to the nondissociative molecular anion FdU−, similar to the long-lived tail 
observed for BrdU [1]. In contrast, CldU shows a transient absorption spectrum similar to 
that for BrdU: it exhibits a single signal peak at the delay time of  ~0.55 ps with one fast 
decay time of 1-2 ps superposed on a long-lived (ns), slow decay tail; the transient 
absorption intensity for CldU is significantly weaker than that for BrdU. The fitted 
transient absorption spectrum, also shown in Figure 4.1, gives a rising time of ~150 fs, a 
fast decay time of 1.5 ps and a slow decay time in ns for CldU, corresponding to the 






























Figure 4.3 (a) Femtosecond time-resolved transient absorption spectra of IdU with various 
concentrations, probed at 330 nm; the dash line is the spectrum for the pure water; (b) Transient 
absorption intensities at 1.0 ps and 10.0 ps versus IdU concentration. 
 
These results are nearly identical to those for BrdU, described in last chapter and in ref. 1. 
It follows that the same excited-state precursor contributes to the formation of BrdU*− 
and CldU*−.  Most strikingly, the transient absorption signal for IdU is much stronger 
than for BrdU and CldU even when the concentration of IdU is about one order of 
magnitude lower.  In other words, the transient absorption signal intensity for IdU is at 
least one order of magnitude higher than those for CldU and BrdU with an identical 
concentration.  In addition, beside the first peak at ~0.5 ps, a second peak is visible at 
~1.0 ps in the transient absorption spectrum for IdU.   These results provide clear 
evidence of two epre− states contributing to the formation of IdU*−. 
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Figure 4.4. Femtosecond transient absorption spectra of 3.6 mM IdU, pumped at 320 nm and 
probed at various wavelengths. The solid lines in red are the best fits to the time-dependent 
transient absorption spectra with a model of four-exponential functions which are convoluted 
with the instrument response function represented by a Gaussian function (see text). The fitted 
rising and decay times are given in table 1. 
 
   
Table 4.1. The results given by the best fits to the time-resolved transient absorption spectra with 
Eq. (4.1): τ1 and τ2 are the rising times, while τ3 and τ4 are the decay times. 
 
λprobe (nm) τ1(fs) τ2(fs) τ3(ps) τ4(ns) 
326 240±50 555±50 2.00±0.20 10 
330 200±50 540±50 1.90±0.02 10 
335 150±50 542±50 1.84±0.02 10 
340 140±50 540±50 1.70±0.20 10 




For the transient absorption spectra measured with probe wavelengths around 330 
nm (in the range of 325-335, Figure 4.4), the best theoretical fits always give two rising 
times and two decay times for each measured spectrum of IdU. The data obtained from 
the best fits using Eq. (4.1) are given in Table 1.  Moreover, the two rising times and two 
decay times are respectively τ1=182 ±50 fs, τ2=544±50 fs,  τ3=1.86 ±0.20 ps and τ4≈10 
ns, with an excellent reproducibility. Similar to the case for BrdU 23 and CldU, the τ1 
rising time, the τ3 and τ4 decay times correspond to the lifetime of an precursor epre−, the 
dissociative lifetime of IdU*− and the lifetime of the long-lived molecular anion IdU−, 
respectively. Below, our discussion is focused on the rising (formation) times (~0.18 and 
0.56 ps) of the transition states XdU*− (X=I, Br and Cl) and the corresponding epre− states 





As mentioned in the Introduction, gas-phase experiments have shown that halouracils (IU, 
BrU and ClU) have very large cross sections of DEA resonances at thermal electron 
energies nearly zero eV [2].  The excess energy ∆E for electron-induced C−X (X=I, Br, 
Cl and F) bond breaks in IdU, BrdU, CldU and IdU in the gas phase can be estimated by 
∆E= EA(X)−EBD ≡ ∆E0, where EA(X) is the electron affinity of the halogen atom X and 
EBD the C-X bond dissociation energy.  In the condensed phase, the excess energy is 
increased by the polarization energy (EP) of the medium: ∆E= ∆E0 + EP [34].  With the 
∆E0 values obtained in the gas phase (∆E0 = −0.9 to −1, 0.01, 0.24 and 0.42 eV for FU, 
ClU, BrU and IU, respectively) [2] and Ep≈1.0 eV for water [35], we estimate that the 
C−X bond breaks for CldU, BrdU and IdU in water are exothermic by 1.01, 1.24 and 
1.42 eV, respectively, while the C−F bond break for FdU in water is nearly thermoneutral 
(∆E ≈ 0 eV).  As schematically illustrated in Figure 4.5, DEA resonances are therefore 
expected to occur for CldU and BrdU with the weakly-bound epre− states that have 
energies slightly higher than the p-like excited state of the hydrated electron.  For IdU, 
interestingly, a second DEA channel can additionally occur with the p-like excited state 
which has a bound energy of ~1.5 eV, very close to the exothermic energy (1.42 eV) for 
DEA of IdU.  In contrast, no precursor states are available for DEA to FdU.  Thus, 
resonant ET from excited-state epre− to XdUs is expected to occur efficiently, leading to 
DEA to IdU, BrdU and CldU with the expected efficiency: IdU>>BrdU>CldU, but no 






























Figure 4.5. Schematic diagram for the energy levels of the equilibrated hydrated electron (esolv−), 
the nonequilibrium precursor (prehydrated) states [ep−(1) and ep−(2) ] and the dissociative electron 
attachment (DEA) resonance levels of halopyrimidines (CldU, BrdU and IdU).  The s-like 
ground state and the p-like excited state (ep−(2)) are located at −3.2 and −1.5 eV, respectively, 
with respect to the vacuum level.  The e−:(H2O)n state, a precursor to the p-like excited state, is 
denoted as ep−(1).  The DEA resonance levels, CldU*−, BrdU*− and IdU*− are located at the 
energies of −1.01, −1.24 and −1.42 eV, respectively.  The electronic band structure of water is 
referred to a recent review by Jay-Gerin and co-workers [22], where the band gap between the 
conduction-band bottom (at ∼−0.75 eV) and the valence-band top is estimated to be in the range 
of 8.2 to 9.2 eV.  Thus, in our two 320 nm-photon excitation (7.8 eV), an electron in the water 
valence band is promoted to an electronic state located at −1.15 to −2.15 eV. 
 
  As also shown in Figure 4.5, there are only small differences in the resonance energies 
for DEA of CldU, BrdU and IdU to form halogen ions and a neutral radical.  Actually, 
the DEA resonant level for IdU is only 0.2 and 0.4 eV below those for BrdU and CldU, 
respectively.  Note that the s-like ground state of es− is located at ~−3.2 eV, which is 1.7 
eV below the p-like excited state.  As a consequence, it is now clearly revealed that both 
the first epre− with a lifetime of 150~200 fs leading to DEAs of all CldU, BrdU and IdU 
and the second epre− with a lifetime of ~544 fs leading solely to DEA of IdU must not be 
s-like ‘hot’ or ‘cold’ electronic ground states, but be electronically excited states of the 
hydrated electron.  According to the electronic structure of liquid water [22], the first 
excited-state epre− subsequent to the two 320 nm-photon excitation (7.8 eV) of water in 
the present experiments lies in an energy of at most −1.15 eV (−1.15  to −2.15 eV).   
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Thus, the present results also indicate that the first excited-state epre− is very close to the 
second p-like excited-state epre− (at ~−1.5 eV) in energy: both are weakly bound excited 
states in the energy range of −1.15 to −1.5 eV, highly reactive for ET reactions.  In 
conclusion, the present results provide direct evidence that both epre− states with lifetimes 
of 150~200 fs and ~544 fs are electronically excited states of es−. This also leads to an 
answer to a long standing debate of whether the “wet electron” with a ~540 fs lifetime is 
an electronically excited state or a ground state of es−.  The absence of these epre− states 
in (H2O)n− clusters [31, 32] may imply that they are related to electrons localized at 





We have obtained real-time observations of the reactions of halopyrimidines with 
precursor electrons generated by ionizing (UV) radiation in water.  This study has 
multiple-fold significance.  First, the present results prove that it is the epre−, rather than 
the hydrated electron, that are responsible for the dissociative electron attachment to 
halopyrimidines.  This reaction leads to the formation of the reactive radical, which is a 
key step in the mechanism of action of these radiosensitizers in radiotherapy of cancers.  
Our results have challenged a long accepted mechanism that long-lived hydrated 
electrons would be responsible for the radical formation in radiolysis of halogenated 
molecules [36] and particularly in radiosensitization of halopyrimidines [13], which 
would predict a formation time of CldU*−, BrdU*− and IdU*− in the time scale beyond ns 
corresponding to the lifetime of hydrated electrons. Second, we have clearly revealed that 
the DEA reaction efficiency is IdU>>BrdU>CldU, whereas no DEA reaction of epre− with 
FdU occurs.  This is due to the availability of two precursor states for DEA to IdU, of 
one precursor state for DEAs to BrdU and CldU, and no precursors for DEA to FdU.  
Thus, IdU should be explored as the most effective radiosensitizer.  Third, our results 
reveal the physical nature of the epre− states and show direct evidence of the long-sought 
wet electron in water, where halopyrimides were indeed employed as 
quantum-state-specific probe molecules. As a more general conclusion, our results 
demonstrate that despite their ultrashort lifetimes in subpicoseconds, nonequilibrium epre− 
can play a crucial role in many ET reactions occurring in aqueous environments, 
especially for chlorine-, bromine- and iodine-containing molecules.  In summary, this 
study can have clear significance for understanding of the role of water in 
electron-initiated reactions and radical chemistry in many chemical, biological and 
environmental systems, ranging from breakups of environmentally important halogenated 
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As briefly mentioned in Chapter 1, one important feature of BrdU/IdU as radiosensitizing 
drugs is the dependence of its radio-/photosensitivity on DNA sequence [1-4].  The 
enhancement of the radio-/photosensitivity with respect to single- and double-strand 
breaks, creation of alkali-labile sites in duplex DNA containing BrdU/IdU was reported 
to be highly dependent on the identity of the nucleic bonded to the 5’- phosphate of 
BrdU/IdU [1-4]. It was observed that UV-irradiated duplexes containing the sequence 
5’-dABrdU (-dAIdU) exhibited most significant DNA damage than analogous molecules 
containing either a 2’-deoxyguanosine (dG) or 2’-deoxycytidine (dC) in place of the 
adjacent 2’-deoxyadenosine (dA). Any true mechanism for the radio-/photosensitization 
of BrdU/IdU must be able to explain this important property.  Some researchers 
suggested that it is due to the electron transfer from the neutral adenine base to BrdU/IdU 
[1-4].  The processes can be expressed as 
 
dA + BrdU/IdU + hν (UV) →dA+ + BrdU*−/IdU*−    (5.1a) 
 
    BrdU*−/IdU*− → Br− + dU• or I− + dU•     (5.1b) 
 
However, in the UV light used with wavelengths above 300 nm, no absorption by the 
DNA bases occurs.  In fact, no dA+ cation, but neutral dA, was detected in the 
experiments [2]. Moreover, this model does not agree with the expectation from the 
thermodynamic point of view, which would predict the most favorable electron transfer 
from the guanine base [5, 6].  So far, no proposed mechanism has been able to explain 
this interesting phenomenon well.  
 
Based on our experimental results described in chapter 3 and 4, once BrdU capture 
electrons, the thus formed transition state, BrdU*−, will quickly dissociate into a bromide 
anion and the highly reactive uracil radical. The latter will then cause single- and 
double-strand breaks, creation of alkali-labile sites, and RNA/DNA-protein 
photo-cross-linking [1-4, 7-13]. We proposed a new mechanism for the sequence 
selectivity of duplex DNA containing BrdU/IdU. In the first step, the DNA nucleoside-dA 
captures the precursor electron, epre−,  generated in ionizing radiation or by two-photon 
excitation of water in UV radiolysis; then the electron transfer from the DNA base 
anion-dA− to BrdU/IdU, which is a very strong electron scavenger, to form the transition 
state BrdU*−/IdU*−. The transition state, BrdU*−/IdU*− then quickly decay, forming the 
reactive uridine-yl radical to damage DNA. The processes can be expressed as: 
 
H2O + 2hν (UV) → H2O* → H2O+ + epre−     (5.2a) 
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dA + epre− → dA−         (5.2b) 
  
dA− + BrdU/IdU →dA + BrdU*−/IdU*−     (5.2c) 
 
    BrdU*−/IdU*− → Br− + dU• or I− + dU•     (5.2d) 
 
 
Looking into the literature carefully, we have found that Nese et al. [14] have proposed a 
very similar mechanism, in which electron transfer from thymine and adenine electron 
adducts and their heteroatomprotonated forms formed by capture of hydrated electrons to 
5-BrU was proposed. Inferred from their measurements of the dU radical yield in 
radiolysis of DNA base-BrU complexes, no electron transfer from the protonated guanine 
electron adduct to 5-BrU was observed.  Instead, there is also electron transfer from the 
electron adduct of thymidine to cytosine and guanine which serve as electron sink [14].  
To examine our proposed mechanism expressed in Eqs. (5.2a-5.2d), it is necessary to 
have real-time observation of the initial DNA base anions and the subsequent electron 
transfer to BrdU/IdU. This will require the time-resolved femtosecond laser spectroscopy 
because of the ultrashort lifetimes of epre−. 
 
  An associated problem is related to the recent breakthrough in radiobiology that DNA 
strand breaks can be induced by low-energy (3-20 eV) electrons (LEEs) [15]. This is of 
great interest because low energy electrons are produced in significant numbers in 
ionizing radiation [16]. Most recently, both experimental and theoretical studies have 
shown that free electrons, even at energies approaching zero eV, can cause induced strand 
breaks in DNA by means of dissociative attachment (DA) of electrons [17-23]. A 
mechanistic understanding of LEE-induced DNA damage is of crucial importance for 
advancement of global models of cellular radiolysis and for the improvement of the 
efficacy of radiotherapy.  There is a current interest in discussing the energy threshold 
for induction of DNA strand breaks by low energy electrons, and several different 
mechanisms for DNA strand breaks induced by LEEs have been proposed [20-23]. One 
central issue is regarding whether DNA strand breaks are initiated by electron attachment 
to DNA bases or to the phosphate group [22, 23]. If the DNA damage is initiated by 
electron attachment to DNA bases, then which base (s) is (are) the low-energy electrons 
attached to and what is the fate of the resultant anions?  And what is the energy 
threshold for DNA strand breaks? So far, these experiments have only been done in dry 
plasmid DNA or in gas-phase DNA bases. Will the dissociative attachment of 
weakly-bound prehydrated electrons cause DNA damage in water?  It has long been 
known that in aqueous environment, nucleotides can react with electrons generated in 
ionizing radiation to form their electron adducts, i.e., their anions [14, 24-26]. Very little 
is known, however, about the electron responsible for the formation of these anions and 
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the stability and subsequent fate of these primary anions in aqueous solution, except that 
they readily react with protons. The protonation of DNA base anions is a relatively slow 
process, however, occurring on the time scale of microsecond [27].  It is likely that our 




5.2 Experimental Details 
 
We used a Ti: sapphire laser system producing 120fs, 1mJ laser pulses centered at λ= 
800 nm at a repetition rate of 1 kHz, two optical parametric amplifiers producing pump 
and probe pulses with wavelengths from visible to IR. The polarization of pump and 
probe pulses was set at the magic angle (54.7º) to avoid contribution from polarization 
anisotropy duo to orientation motions of molecules. To avoid the direct absorption of the 
pump pulse by DNA bases, a pump wavelength 315 nm was used in these experiments. 
Excess electrons are produced by a two-photon excitation process in water [28-32]. The 
probe wavelengths 333 nm were selected to search the transition states (dXMP*−) of the 
reactions of the mononucleotides of adenine, cytosine, guanine and thymidine, (dXMP, 
X= A, C, G and T) with the precursors to the hydrated electron [32]. Small pump pulse 
energy (≤ 100nJ) was used to make the solvated electron signal negligible when detected 
at (probe) wavelength 333 nm and to avoid any nonlinear effects. Since the pump and 
probe wavelengths are now close to each other, a coherent ‘spike’ unavoidable appears at 
the delay time zero, which is clearly seen in the spectrum for the pure water. This 
“unwanted” spike, however, offers not only a visible and reliable in-situ reference for the 
pump-probe delay time zero but the instrument response function. In our experiments, an 
instrument response function of 300 fs was directly given by the full width at half 
maximum (FWHM) of the coherent spike. Transient absorption spectra of dXMP*− are 
corrected by subtracting the spectrum of the pure water (solvent) from the collected 
spectra; this also significantly reduces or completely removes the coherent spike from the 
spectra. All measurements are conducted at room temperature. The sample was held in a 
5mm cell with a stirring bar to avoid any photoproduct accumulation. Ultrapure water 
with a resistivity of > 18 MΩ/cm was obtained from an ultrapure water system 
(Barnstead’s Nanopure Diamond TOC Life Science). Nucleotides (dAMP, TMP, dGMP 
and dCMP) from Sigma-Aldrich were used as supplied. 
 
 
5.3 Results and Discussion 
 
Femtosecond transient absorption spectra of dXMPs obtained with λpump = 315 nm and 
λprobe = 333 nm are shown in Figure 5.1(a) and (b). The interesting results observed are 
the following: 
 48
   
























































Figure 5.1. Femtosecond transient absorption spectra of 50mM dAMP, 50mM dGMP, 50mM 
dCMP and 50mM dTMP in water, pumped at 315nm and probed at 333nm: (a) original data, 
where the sharp peak at time zero is the coherence “spike” observed when λpump and λprobe are 
close to each other; (b) spectra obtained after the subtraction of the spectrum for the pure water.  
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(1) The attachment of the ultrashort-lived prehydrated electrons to DNA bases was 
indeed observed, which takes place within the first picosecond after electronic 
excitation of water. 
(2) dGMP has the largest probability of electron capture, among the 4 nucleotides.  
(3) dAMP is the most effective for long-lived trapping of the precursor electron. 
(4) Compared with dGMP and dAMP, the electron capture probabilities of dTMP and  
    of dCMP are much smaller. 
(5) dGMP*− and dTMP*− show quick decays in the first three picoseconds, indicating 
they are dissociative, i.e. dissociative attachments (DAs) of the prehydrated electron 
to dGMP and dTMP occur.  
 
As shown in Figures 5.2 and 5.3 for dAMP and dGMP respectively, the transient 
absorption spectra of nucleotide anions simply exhibit a linear dependence on nucleotide 
concentration in the measured range of 25 to 100 mM. This indicates that the transient 
species must result from a single nucleotide molecule.  
 



















































               
Figure 5.2. Femtosecond transition absorption spectrum of different concentration of dAMP in 
water, pumped at 315nm and probed at 333nm. The inset is the transient absorption at 5.0 ps as a 
function of dAMP concentration. 
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Figure 5.3. Femtosecond transition absorption spectrum of different concentration of dGMP in 
water, pumped at 315nm and probed at 333nm. The inset is the transient absorption at 7.6 ps as a 
function of dGMP concentration. 
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Figure 5.4. Femtosecond transient absorption spectra of 50mM dAMP in water, pumped at 
315nm with various pulse energies and probed at 333 nm, after the subtraction of the spectrum 
for the pure water. The inset is the square root (SQRT) of the transient absorbance at 1.9 ps vs 
pump pulse energy. 
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As shown in Figure 5.4., moreover, the yield of the transient absorption of dAMP at 
333nm shows a quadratic dependence on the pump pulse energy. This result confirms that 
the transition states result from the electrons, generated by two photon excitation of the 
water.  
 
Most interestingly, the results in Figure 5.1 demonstrate that the transition state 
dGMP*− quickly decays in the first few picoseconds, indicating that DA occurs for dGMP.  
In contrast, dAMP*− is nondissociative, having a long lifetime.  These results indicate 
that the electron can be trapped by adenine for a long lifetime and can be efficiently 
transferred to BrdU/IdU when adenine is adjacent to BrdU/IdU. This can explain why the 
sequence 5’-dABrdU (-dAIdU) exhibits most significant enhancement in the induced 
radio-/photosensitivity (DNA damage) [1-4], though further confirmation of the electron 
transfer from dA− to BrdU/IdU is yet to be done.  This will also imply that adenine is an 
effective promoter for electron transfer reactions in biological systems. In contrast, 
guanine base exhibits the most effective dissociative electron attachment, which leads to 
the formation of a stable anion and a neutral counterpart.  Thus, guanine was also 
observed to be the most effective electron sink [14].  The present results are drastically 
different from those reported for DNA bases in the gas phase, where dissociative 
attachment of free electrons (0-10 eV) to all four bases have been reported, including 
adenine, guanine, cytosine and thymine [17-23].  Our results indicate that DNA strand 
breaks can efficiently be induced by dissociative attachment of the weakly-bound 
precursor electron to the guanine base. Indeed, we have observed significant DNA 
single-strand breaks induced by the production of precursor electrons via two-photon 
excitation of water containing plasmid DNA [33]. Further experiments to measure the 
dissociation products of guanine by attachment of the precursor electron will be 





We have observed the ultrafast electron transfer reactions of the nucleotides (dAMP, 
dGMP, dCMP, and dTMP) with the precursors to the hydrated electrons. The present 
results indicate that adenine is the most efficient electron trapper and an effective electron 
transfer promoter. The observed results primarily explain the sequence selectivity of 
duplex DNA containing BrdU/IdU. Our results also imply that dissociative attachment of 
the precursor electron to guanine takes place rapidly, which can be an important 
mechanism for electron-induced DNA damage in radiation biology and radiotherapy of 
cancer. More work to confirm the electron transfer reactions between dA− and BrdU/IdU 
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We have performed state-of-the-art time-resolved femtosecond laser spectroscopic 
experiments on a chemically, biologically and practically significant system, namely 
halopyrimidines, and have obtained the first, real-time observation of the ultrafast 
electron transfer (ET) reactions involving the short-lived precursor to the hydrated 
electron, epre-, that leads to the formation of the transient CldU*-, BrdU*-, IdU*- states.  
The latters dissociate into halogen anions and a highly reactive radical that then causes 
DNA damage and cell death.  
 
This is the first, direct observation of the ultrafast ET reactions of the precursor to the 
solvated electron with biologically important molecules, and our results lead to a new 
mechanism of action at the molecular level of halopyrimidines as candidate drugs for 
radiotherapy of cancer.  We find that the ET reaction efficiency is in the order of 
CldU<BrdU << IdU. This is due to the availability of two precursor states for DEA to 
IdU, of one precursor state for DEAs to BrdU and CldU, and no precursors for DEA to 
FdU. Among halopyrimidines, IdU should be explored as the most promising 
radiosensitizing drug. Efforts should be made to promote the ET reactions of these 
radiosensitisers with precursor electrons in order to enhance the therapeutic efficacy. 
 
Moreover, our results have revealed the physical nature of the epre− states and show 
direct evidence of the long-sought wet electron in water, where halopyrimidines were 
indeed employed as quantum-state-specific probe molecules.  We also provide direct 
evidence of the excited-state model of the long-sought “wet” electron that has a lifetime 
of ~0.54 ps. 
 
These findings will also have a broader significance as they indicate that 
nonequilibrium precursor electrons may play an important role in electron-initiated 
reactions in many biological and environmental systems.  The precursor electron is a 
general product in ionizing/UV radiation.  Our results have challenged a long accepted 
mechanism that long-lived hydrated electrons would be responsible for the radical 
formation in reactions with halogen-containing molecules.  In summary, this study can 
have clear significance for understanding of the role of water in electron-initiated 
reactions and radical chemistry in many chemical, biological and environmental systems, 
ranging from breakups of environmentally important halogenated molecules to the 
activation of halogen-containing anticancer drugs. 
 
The ultrafast electron transfer reactions of nucleotides with the prehydrated electron 
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primarily explain the sequence selectivity of duplex DNA containing BrdU/IdU. The 
results also imply that dissociative attachment of the precursor electron to guanine takes 
place rapidly, which can be an important mechanism for radiation-induced DNA damage 
in ionizing radiation and radiotherapy of cancer.  Future work will be done (1) to 
demonstrate the electron transfer reactions between the electron adduct of nucleotides 
(especially dA−) and BrdU/IdU, (2) to clarify the dissociation products of dGMP*−, and 
(3) to precisely chracterize the DNA damage induced by the reactions of prehydrated 
electrons generated in ionizing radiation.   
 
With our femtosecond laser spectroscopy, it is promising for us to (1)determine the 
precise reaction mechanism at the molecular level of BrdU and IdU as 
radio-/photosensitizing drugs for cancer therapy and DNA/RNA-protein 
photocrosslinking, (2) to identify the molecular triggers for enhancement or control of the 
reactivity of BrdU and IdU, and (3) to make these candidate anticancer drugs more 
effective so that the BrdU and IdU could go through the final clinical trials, taking 
advantage of our mechanistic understanding of the reactions of these molecules at the 
molecular level.  
